Tara Moroz, PhD, smiling in a blue blazer.

There's more to better.

Exploring the space between the promise of better and meaningful progress.

Founded by Tara Moroz, PhD, Beyond the Buzz Media explores why promising ideas capture our attention, what the evidence supports, and what makes improvement meaningful in real life.

Through a weekly podcast, evidence-informed writing, speaking, and a book in development, Tara brings scientific judgment, curiosity, and human perspective to the ideas shaping our lives.

Short, evidence-informed episodes — usually around 10 minutes.

Beyond the Buzz is the flagship recurring podcast from Beyond the Buzz Media: short, evidence-informed episodes examining health, technology, culture, and business questions already attracting meaningful public attention.

Each week, Dr. Tara Moroz does the research so you don’t have to — finding and weighing the relevant evidence and translating it into a clear, practical bottom line.

Every Beyond the Buzz episode is accompanied by The Evidence Edit, featuring the full transcript, complete references, and what the evidence still can't tell us.

Why Beyond the Buzz?

New ideas capture our attention for a reason. They promise to make something better, easier, healthier, or more interesting. And sometimes they deliver.

Beyond the Buzz explores what makes those possibilities compelling, follows the strongest relevant evidence, and brings the findings back to everyday life.

The reward isn't just knowing what holds up. It's gaining the perspective to decide what's genuinely worth your attention.

Meet Tara Moroz, PhD

Beyond the Buzz is created and hosted by Tara Moroz, PhD, a scientific strategist and communicator with 25 years of pharmaceutical experience across Canadian, U.S., and global roles.

Her career in pharmaceutical science and Medical Affairs shaped a question that now guides her broader work: what separates the promise of better from meaningful progress?

Today, through Beyond the Buzz Media, Tara explores why promising ideas capture our attention, what the evidence actually supports, and what makes improvement meaningful in everyday life.

The Evidence Edit — go deeper.

Each Beyond the Buzz episode has a corresponding edition of The Evidence Edit, featuring the full transcript, complete references, and what the evidence still cannot tell us.

Designed for curious adults who want to go deeper, it makes the research transparent and easy to revisit — what people are hearing, what the evidence supports, what remains uncertain, and how the evidence was weighed.

The Evidence Edit also features Selected Writing — a collection of Tara's independently published articles and essays in outlets including Scientific American, Healthy Debate, and Life Sciences Review Europe.

How the evidence works.

Each Beyond the Buzz podcast episode distinguishes between what people are hearing and what the relevant evidence supports, while exploring why an idea may be compelling.

This podcast-specific research approach is guided by the evidence-integrity standards shared across Beyond the Buzz Media.

In each investigation, Tara considers:

• Hype: the headlines, viral posts, marketing claims, and public conversation shaping the buzz

• Evidence: research, data, and authoritative sources matched to the question and weighed for quality, consistency, applicability, and limits

• Why the Buzz Resonates: the psychological, cultural, practical, emotional, algorithmic, workplace, economic, commercial, or institutional factors that can make an idea compelling — context, not proof

Media, speaking & partnerships.

Speaking & Keynotes

Tara's featured keynote, The Promise of Better: What Makes Progress Meaningful?, explores why we're drawn to new possibilities and what separates exciting innovations from benefits that genuinely matter.

Drawing on 25 years in pharmaceutical science and Medical Affairs, she brings a distinctive perspective to audiences across health, wellness, science, technology, and business.

Tara is also available for media interviews, selected workshops, strategic advisory work, and evidence-aligned partnerships.

Commercial relationships never influence topic selection, evidence interpretation, editorial judgment, or bottom-line conclusions.